GlassScriptPhysician profile
Lawrence Robert Hufford
NPI 1467547190
$1,934.10
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,568 · 2020: $366.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $870.30 | 2019 | |
| Horizon Therapeutics Plc | $232.39 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $184.51 | 2019 | |
| Smith+Nephew, INC. | $137.78 | 2019-2020 | |
| Bioventus LLC | $132.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $119.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $94.33 | 2019 | |
| Paratek Pharmaceuticals, INC. | $63.13 | 2020 | |
| Sandoz INC. | $38.10 | 2020 | |
| Kci USA, INC. | $19.36 | 2020 | |
| Organogenesis INC. | $15.27 | 2019 | |
| Medartis INC. | $15.13 | 2019 | |
| Roche Diagnostics Corporation | $11.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Hufford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.